Hartley Dylan has filed 3 insider transactions across 1 company since October 2024.
Most recent transaction: a grant/award of 110000 shares of OnKure Therapeutics, Inc. ($OKUR) on April 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | OnKure Therapeutics, Inc. | $OKUR | Hartley Dylan | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 110000 | $0.00 | 110,000.0000 | 13,530,892 | 9999.99% | 0.81% |
| Jan. 27, 2025 | OnKure Therapeutics, Inc. | $OKUR | Hartley Dylan | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 3,447,071 | 9999.99% | 1.31% |
| Oct. 4, 2024 | OnKure Therapeutics, Inc. | $OKUR | Hartley Dylan | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 137603 | $0.00 | 137,603.0000 | 316,142 | 9999.99% | 43.53% |